UK markets close in 7 hours 14 minutes

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
26.25-0.62 (-2.31%)
At close: 04:00PM EDT
26.40 +0.15 (+0.57%)
After hours: 06:38PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.81B
Enterprise value 2.44B
Trailing P/E 478.56
Forward P/E 111.11
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.92
Price/book (mrq)7.72
Enterprise value/revenue 9.54
Enterprise value/EBITDA -15.18

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3-23.03%
S&P500 52-week change 313.11%
52-week high 342.48
52-week low 323.09
50-day moving average 329.63
200-day moving average 332.40

Share statistics

Avg vol (3-month) 3900.55k
Avg vol (10-day) 3791.07k
Shares outstanding 5107.19M
Implied shares outstanding 6107.19M
Float 8103.94M
% held by insiders 14.96%
% held by institutions 170.74%
Shares short (14 Sept 2023) 46.1M
Short ratio (14 Sept 2023) 46.81
Short % of float (14 Sept 2023) 46.78%
Short % of shares outstanding (14 Sept 2023) 45.69%
Shares short (prior month 14 Aug 2023) 46.06M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 316 Nov 2011

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin -70.69%
Operating margin (ttm)-70.45%

Management effectiveness

Return on assets (ttm)-14.58%
Return on equity (ttm)-43.03%

Income statement

Revenue (ttm)256.21M
Revenue per share (ttm)2.41
Quarterly revenue growth (yoy)-51.20%
Gross profit (ttm)243.23M
EBITDA -169.21M
Net income avi to common (ttm)-181.11M
Diluted EPS (ttm)-1.70
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)451.7M
Total cash per share (mrq)4.21
Total debt (mrq)345.8M
Total debt/equity (mrq)90.53%
Current ratio (mrq)6.70
Book value per share (mrq)3.41

Cash flow statement

Operating cash flow (ttm)-197.37M
Levered free cash flow (ttm)-226.58M